Press Releases
Press Release
Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.
March 18, 2020
Press Release
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation
March 05, 2020
Press Release
Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada
January 15, 2020
Press Release
Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor
December 18, 2019
Press Release
Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to its Board of Directors
December 03, 2019
Press Release
Cardiol Therapeutics comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency
November 25, 2019
Press Release
Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx™100
November 19, 2019
Press Release
Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx™100
October 01, 2019
Press Release
Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th
September 05, 2019
